FAB
First Trust Multi Cap Value AlphaDEX Fund
First Trust Multi Cap Value AlphaDEX Fund seeks investment results that correspond to the Defined Multi Cap Value Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 139.0 M
ASSETS UNDER MGMT
67 bp
EXPENSES
Fund Basics
| Inception date | May 08, 2007 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SUPER MICRO COMPUTER, INC. | 0.5 % |
| SYNCHRONY FINANCIAL | 0.5 % |
| MCCORMICK & CO-NON VTG SHRS | 0.5 % |
| ELEVANCE HEALTH INC | 0.5 % |
| SMURFIT WESTROCK PLC | 0.5 % |
| P G & E CORP | 0.5 % |
| UNITED CONTINENTAL HOLDINGS | 0.5 % |
| ANNALY CAPITAL MANAGEMENT IN | 0.5 % |
| DR HORTON INC | 0.5 % |
| EDISON INTERNATIONAL | 0.5 % |
Constituent Breakdown
| Number of holdings | 675 |
| Herfindahl-Hirschman Index | 23 |
| Wgt avg mkt cap (mns) | $35,675 |
| Large cap (>$10bn) | 55.0% |
| Mid cap ($2-10bn) | 31.9% |
| Small cap (<$2bn) | 11.3% |
| Developed mkts. | 99.0% |
| Emerging mkts. | 0.1% |
Sector Breakdown
Country Exposure
| UNITED STATES | 94.4 % | |
| BERMUDA | 1.8 % | |
| IRELAND | 1.4 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.1% | 18.9% | 7.0% | 10.7% | 6.5% | 8.2% | -- | 6.3% |
| Dividend Yield | 0.4% | 2.1% | 2.0% | 2.1% | 2.0% | 1.9% | -- | 1.7% |
| Total Returns | 6.5% | 21.0% | 9.0% | 12.8% | 8.5% | 10.1% | -- | 8.0% | Ann. Volatility | 13.8% | 20.0% | 17.8% | 17.3% | 18.8% | 22.1% | -- | 24.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.86 | 67% |
| MSCI EAFE | 0.81 | 51% |
| MSCI Emg Mkts | 0.60 | 36% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $95.64 |
| Relative strength (RSI) | 63 |
| MACD/Signal | 0.89/0.48 |
| Bollinger Bands (Upper/Lower) | $98.89/$91.80 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FAB |
Expenses vs. FAB |
ALTAR Score™ vs. FAB |
|---|---|---|---|---|
| FTA | First Trust Large Cap Value AlphaDEX Fund | 49.3% | -8 bp | -0.9% |
| FEX | First Trust Large Cap Core AlphaDEX Fund | 47.7% | -8 bp | -3.3% |
| VFVA | Vanguard U.S. Value Factor ETF | 37.6% | -54 bp | +0.9% |
| STXV | Strive 1000 Value ETF | 35.1% | -49 bp | -1.5% |
| DEUS | Xtrackers Russell US Multifactor ETF | 34.7% | -50 bp | -1.8% |
| IMCV | iShares Morningstar Mid-Cap Value ETF | 33.9% | -61 bp | -1.3% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 33.9% | -47 bp | -2.7% |
| IWS | iShares Russell Mid-Cap Value ETF | 33.8% | -44 bp | -2.4% |
| ISCV | iShares Morningstar Small Cap Value ETF | 33.7% | -61 bp | -0.8% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 33.5% | -49 bp | -2.4% |
Risk and Returns: FAB vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/21/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
9.0%
ALTAR SCORE™
96th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. FAB's ALTAR Score™ is approximately 1.7 standard
deviations above the category average. This places FAB in the 96th percentile
among funds in the category.
Sell-Side Consensus
$115.16
PRICE TARGET
+16.0%
UPSIDE